If you’ve acquired a pattern pack of Taytulla contraception drugs out of your physician in current months, beware: the producer put the placebo drugs within the mistaken place.
Allergan, the producer of Taytulla, introduced Tuesday that it was issuing a nationwide recall of 1 lot of the drugs, totaling practically 170,000 packs, after being notified of a packaging error by a doctor.
In the affected packs, the primary 4 drugs within the pack—somewhat than the final 4—had been inactive, doubtlessly placing ladies liable to being pregnant. According to a press release, the packaging error meant that the primary 4 days within the pack contained the maroon placebo capsules. Typically, the packages comprise 24 days of pink capsules with oral contraceptive hormones, that are then adopted by the maroon placebo capsules.
The producer is anxious that customers of their contraceptive could not discover the reversed order, thereby rising the opportunity of an unintended being pregnant.
The pattern packs have been in circulation nationwide since August. Those affected are marked lot #5620706 with an expiration date of May 2019. Allergan is voluntarily recalling all of the models within the lot.
Allergan mentioned it’s notifying clients of the recall by letter and inspired sufferers to contact their docs with any questions. Shares of the corporate dropped shut to 2% on Tuesday following information of the recall.